Idarucizumab (Praxbind) Dabigatran Reversal Dosing

Provides idarucizumab dosing for urgent dabigatran reversal: 5 g IV (2 × 2.5 g vials administered consecutively) for life-threatening bleeding or urgent surgery. Reversal is complete within minutes and sustained for at least 24 hours in most patients (RE-VERSE AD trial).

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How to Use

Enter the values for the scenario you are assessing. Provides idarucizumab dosing for urgent dabigatran reversal: 5 g IV (2 × 2.5 g vials administered consecutively) for life-threatening bleeding or urgent surgery. Reversal is complete within minutes and sustained for at least 24 hours in most patients (RE-VERSE AD trial). Use the idarucizumab dabigatran reversal result to inform your calculation.

Related Calculators

Andexanet Alfa Dosing

Medical

Warfarin PCC Reversal

Medical

INR Interpretation

Medical

Frequently Asked Questions